本文關(guān)鍵詞： 霍亂弧菌腸毒素B亞單位 大腸桿菌 雙歧桿菌 基因克隆 蛋白表達(dá)　出處：《第一軍醫(yī)大學(xué)》2006年碩士論文　論文類型：學(xué)位論文

【摘要】：研究背景： 霍亂(Cholera)是一種由霍亂弧菌(Vibrio cholerae)引起的烈性傳染病，一直以來都是各國(guó)傳染病防治的重點(diǎn)，免疫接種是預(yù)防霍亂的最有效措施。以前的注射用疫苗不同程度存在著各種缺點(diǎn)，研究也顯示針對(duì)霍亂這種腸道傳染病的疫苗，通過口服途徑給予的效果優(yōu)于其他任何胃腸外給予途徑，因?yàn)槟c道粘膜免疫在霍亂的免疫預(yù)防中發(fā)揮著主要作用。因此，開發(fā)安全、方便、價(jià)廉的口服疫苗成為霍亂免疫預(yù)防研究的熱點(diǎn)，而以霍亂弧菌腸毒素(Cholera toxin，CT)為基礎(chǔ)的基因重組口服疫苗成為霍亂疫苗開發(fā)的主要方向。CT是霍亂弧菌主要的致病因子，它是分子量為84KD的腸毒素，由1個(gè)A亞單位(Cholera toxin Asubunit，CTA)和5個(gè)B亞單位(Cholera toxin B subunit，CTB)形成的五聚體共價(jià)連接而成，CTA為毒性亞單位，CTB為無毒的受體結(jié)合亞單位，后者是霍亂的主要保護(hù)性抗原。口服CTB可以刺激機(jī)體產(chǎn)生保護(hù)性粘膜抗體和血清抗體，發(fā)揮霍亂防治作用。此外，CTB還是一種很好的粘膜免疫佐劑，用于強(qiáng)化多糖、小肽等半抗原的免疫原性，與其他不相關(guān)抗原共同使用時(shí)，可以促進(jìn)誘導(dǎo)其他抗原的粘膜免疫反應(yīng)，，用于更廣泛的人類疫苗的發(fā)展。所以，為充分發(fā)揮CTB的免疫特性作用，探索CTB在各種宿主表達(dá)的研究日益增多，如細(xì)菌、植物、
[Abstract]:Research background:
Cholera (Cholera) is a kind of Vibrio cholerae (Vibrio cholerae) caused by infectious diseases, has been the focus of the prevention and treatment of infectious diseases, vaccination is the most effective measure for the prevention of cholera. Previous vaccines had many defects in different degrees. This study also showed that for cholera intestinal infectious disease vaccine that effect was given via the oral route is better than any other way for parenteral administration, intestinal mucosal immunity plays a major role in the immune prevention of cholera. Therefore, the development of safe, convenient, inexpensive oral disease prevention research has become the focus of vaccine immunity to cholera, cholera toxin (Cholera toxin CT) gene recombinant oral vaccine based cholera vaccine development has become the main direction of.CT is the main pathogenic factor of Vibrio cholerae, which is a molecular weight of 84KD enterotoxin, composed of 1 A subunits (Cholera to Xin Asubunit, CTA) and 5 B (Cholera toxin B subunit subunit, CTB) five dimer formation of covalent connection, CTA is the toxic subunit, CTB is a non-toxic receptor binding subunit, which is the major protective antigen of cholera. Oral CTB can stimulate the body to produce protective antibody and mucosa serum antibodies play a protective role for cholera. In addition, CTB is also a very good immunologic adjuvant, to enhance the immunogenicity of polysaccharides, small peptide hapten, use with other incorrelate antigen, inducing other antigens can promote mucosal immune response, for the wider human vaccine development so, to give full play to the role of the immune characteristics of CTB, to explore the expression of CTB in various host has increased, such as bacteria, plant,

【學(xué)位授予單位】：第一軍醫(yī)大學(xué)
【學(xué)位級(jí)別】：碩士
【學(xué)位授予年份】：2006
【分類號(hào)】：R378

【參考文獻(xiàn)】

相關(guān)期刊論文 前10條

1 張秀榮,陳穗,楊海濤,潘令嘉,周殿元;廣州地區(qū)健康青、老年人腸道菌群的調(diào)查[J];第一軍醫(yī)大學(xué)學(xué)報(bào);1988年04期

2 彭志強(qiáng),俞守義,余迪求,賀竹梅;編碼霍亂腸毒素B亞單位基因植物表達(dá)載體的構(gòu)建[J];第一軍醫(yī)大學(xué)學(xué)報(bào);2002年08期

3 郭志英,易成,王樹人,王浩毅;嬰兒雙歧桿菌/胞嘧啶脫氨酶腫瘤靶向性基因治療系統(tǒng)的構(gòu)建[J];中國(guó)肺癌雜志;2004年02期

4 李寧軍,李琳,江培,李盛

本文編號(hào)：1541941